Hsing‐Tao Kuo

机构：National Sun Yat-sen University, Chi Mei Medical Center · ORCID：0000-0002-5841-974X

发表论文 112 篇 · 总被引 1543 次 · h-index 22

代表论文

Glucagon‐Like Peptide‐1 Receptor Agonists and Liver Outcomes in Patients With MASLD and Type 2 Diabetes (2025 · Alimentary Pharmacology & Therapeutics · 被引 33)
Semaglutide and the risk of adverse liver outcomes in patients with nonalcoholic fatty liver disease and type 2 diabetes: a multi-institutional cohort study (2024 · Hepatology International · 被引 23)
Impact of GLP ‐1 Receptor Agonists on Alcohol‐Related Liver Disease Development and Progression in Alcohol Use Disorder (2025 · Alimentary Pharmacology & Therapeutics · 被引 21)
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy (2024 · Clinical and Molecular Hepatology · 被引 18)
Glucagon-like peptide-1 receptor agonists and gastrointestinal cancer risk in individuals with type 2 diabetes (2025 · Diabetologia · 被引 13)
Semaglutide versus other GLP-1 receptor agonists in patients with MASLD (2025 · Hepatology Communications · 被引 9)